StockWatch
·
Biotechnology: Pharmaceutical Preparations
Board MeetingJun 18, 2026, 05:01 PM

Teva Releases Q2 2026 Aide Memoire; Q2 Results July 29

AI Summary

Teva Pharmaceutical Industries Ltd. announced the availability of its Q2 2026 Aide Memoire on its investor website. This document compiles previously released public information to help investors prepare for the second quarter 2026 results. The company expects to release its Q2 2026 results on Wednesday, July 29, 2026, at 7:00 a.m. ET, followed by a conference call at 8:00 a.m. ET on the same day.

Key Highlights

  • Teva released its Q2 2026 Aide Memoire to assist investors.
  • Q2 2026 results are expected to be released on Wednesday, July 29, 2026, at 7:00 a.m. ET.
  • A conference call will follow the results release at 8:00 a.m. ET on the same day.
  • The Aide Memoire compiles public information previously provided by Teva.